Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Blood Advances
Published October 2, 2026
An Electronic Frailty Index Is Associated with Outcomes in Older Adults Receiving CAR-T Therapy.
October 3, 2026
Medspoke
Medspoke
Blood Advances
Published October 2, 2026
00:00
--:--
Phase 1/2 study of favezelimab plus pembrolizumab in anti-PD-1-naive relapsed or refractory class...
October 3, 2026
Share
Phase 1/2 study of favezelimab plus pembrolizumab in anti-PD-1-naive relapsed or refractory classical Hodgkin lymphoma.
https://www.medspoke.co/channel_journal?id=683&tap_id=14998
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Leukemia
Published October 2, 2026
Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: sa...
October 3, 2026
Why are you reporting this TALK?